MDCKII Cell-based Plates for In Vitro Drug-transporter Studies
ReadyCell has developed an advanced range of MDCKII Cell-based Plates for In Vitro Drug-transporter Studies in preclinical testing and drug
Read more
Drug Discovery
Caco-2 and HT-29 Co-culture Intestinal Absorption Cell-based Plates
The Caco-2 and HT-29 Co-culture Intestinal Absorption cell-based plates are a ready-to-use in vitro cell-based model for intestinal absorption evaluation
Read more
Caco-2 Permeability Cell-based Plates
The Caco-2 Permeability Cell-based Plates offer a ready-to-use solution for evaluating the in vitro intestinal absorption of drug targets. The
Read more
Genentech and NVIDIA Join Forces for AI-Powered Drug Discovery
American biotechnology corporation Genentech, a key player in research and early drug development and a subsidiary of the Roche Group,
Read more
Assay for Predicting Intestinal Permeability & Volume of Distribution
Predicting the pharmacokinetics of new chemical entities in humans is a powerful ability for drug discovery and development. Off-the-shelf Intestinal
Read more
Parkinson’s Disease Research Products
StressMarq manufactures and offers a wide range of products specifically developed to accelerate Parkinson’s disease research. StressMarq’s cutting-edge product range
Read more
Pre-plated Cell-based Assays for Drug Discovery – Video
ReadyCell’s cutting-edge pre-plated cell-based assays are developed to accelerate and streamline drug discovery and development studies. The Benefits of Utilising
Read more
Pfizer Enters $331 Million RNA Discovery Collaboration with Ginkgo Bioworks
American biotech company Ginkgo Bioworks announced a new collaboration with Pfizer focused on the discovery of RNA-based drug candidates. The
Read more
Breaking Free from Commercial Limitations with Custom Chemical Synthesis
In the vast landscape of pharmaceutical research and development, one significant challenge that researchers face is the availability of suitable
Read more
Orano Med Partners with Biosynth to Develop New Targeting Vector for Radioligand Therapies
Orano Med, a clinical-stage biotechnology company that develops the next generation of targeted therapies against cancer using the unique properties
Read more